Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Skorpios Trust — Stoke Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Skorpios Trust

Skorpios Trust

10% owner at Stoke Therapeutics, Inc. · on record since Jun 30, 2021
10% owner at Akero Therapeutics, Inc. · on record since Jun 30, 2021
Former 10% owner at Akero Therapeutics, Inc. · on record since Dec 5, 2022

Insider trading activity of Skorpios Trust

Transactions on record: 2; since Dec 5, 2022

Open-market buys: 0

Open-market sells: 2; $101.8M

Companies traded: 2; last filing Jun 6, 2025

Figures computed from official regulatory filings — methodology.

Companies where Skorpios Trust has traded

Stoke Therapeutics, Inc.1 tx · $30.6M · Jun 6, 2025
Akero Therapeutics, Inc.1 tx · $71.2M · Dec 5, 2022

Track record of Skorpios Trust

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Skorpios Trust

Co-insiders of Skorpios Trust

Apple Tree Partners IV, L.P.Akero Therapeutics, Inc. +1
ATP III GP, Ltd.Akero Therapeutics, Inc. +1
Blue Horizon Enterprise LtdAkero Therapeutics, Inc. +1
Ezbon International LtdAkero Therapeutics, Inc. +1
Green JeremyAkero Therapeutics, Inc. +1
Harrison Seth LoringAkero Therapeutics, Inc. +1
Montrago Trustees LtdAkero Therapeutics, Inc. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Redmile Group, LLCAkero Therapeutics, Inc. +1

Adelman Robert JAkero Therapeutics, Inc.

Allan JonathanStoke Therapeutics, Inc.

Atlas Venture Associates Opportunity I, LLCAkero Therapeutics, Inc.

Atlas Venture Associates Opportunity I, L.P.Akero Therapeutics, Inc.

Atlas Venture Associates XI, LLCAkero Therapeutics, Inc.

Atlas Venture Associates XI, L.P.Akero Therapeutics, Inc.

Atlas Venture Fund XI, L.P.Akero Therapeutics, Inc.

Atlas Venture Opportunity Fund I, L.P.Akero Therapeutics, Inc.

Bitterman KevinAkero Therapeutics, Inc.

Burstein JenniferStoke Therapeutics, Inc.

Cheng AndrewAkero Therapeutics, Inc.

Gangloff Scott A.Akero Therapeutics, Inc.

GOODMAN COREY SAkero Therapeutics, Inc.

Graham G. WalmsleyAkero Therapeutics, Inc.

Hall Samuel W.Stoke Therapeutics, Inc.

Henderson JaneAkero Therapeutics, Inc.

Heyman Tomas J.Akero Therapeutics, Inc.

Hoitt JasonStoke Therapeutics, Inc.

Iwicki Mark TAkero Therapeutics, Inc.

Judy ChouAkero Therapeutics, Inc.

Kahn ClareStoke Therapeutics, Inc.

Kaye Edward M. MDStoke Therapeutics, Inc.

Krainer Adrian R.Stoke Therapeutics, Inc.

Lamy PatrickAkero Therapeutics, Inc.

Leggett ThomasStoke Therapeutics, Inc.

LEVIN ARTHUR AStoke Therapeutics, Inc.

Liau GeneStoke Therapeutics, Inc.

Menzel Garry EStoke Therapeutics, Inc.

Nash Huw M.Stoke Therapeutics, Inc.

Rolph TimothyAkero Therapeutics, Inc.

Royston AaronAkero Therapeutics, Inc.

RTW INVESTMENTS, LPStoke Therapeutics, Inc.

SMITH IAN FStoke Therapeutics, Inc.

Smith JulieStoke Therapeutics, Inc.

Ticho BarryStoke Therapeutics, Inc.

Tulipano Stephen JStoke Therapeutics, Inc.

TZIANABOS ARTHURStoke Therapeutics, Inc.

venBio Global Strategic Fund II L.P.Akero Therapeutics, Inc.

venBio Global Strategic GP II, L.P.Akero Therapeutics, Inc.

venBio Global Strategic GP II, Ltd.Akero Therapeutics, Inc.

Versant Venture Capital VI, L.P.Akero Therapeutics, Inc.

Versant Ventures VI GP-GP, LLCAkero Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Stoke Therapeutics, Inc.	Jun 6, 2025	Sell	-3,000,000	10.20 USD	$30.6M	SEC
Akero Therapeutics, Inc.	Dec 5, 2022	Sell	-1,636,000	43.50 USD	$71.2M	SEC